Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Capricor Therapeutics (CAPR) has a market cap of $0.68 billion USD. According to our data, Capricor Therapeutics is ranked No.5728 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $0.68 B |
7.97%
|
| Dec 31, 2024 | $0.63 B |
182.21%
|
| Dec 29, 2023 | $0.22 B |
26.68%
|
| Dec 30, 2022 | $0.18 B |
31.74%
|
| Dec 31, 2021 | $0.13 B |
-14.58%
|
| Dec 31, 2020 | $0.16 B |
167.97%
|
| Dec 31, 2019 | $58.20 M |
-68.78%
|
| Dec 31, 2018 | $0.19 B |
-74.05%
|
| Dec 29, 2017 | $0.72 B |
-40.60%
|
| Dec 30, 2016 | $1.21 B |
-13.36%
|
| Dec 31, 2015 | $1.40 B |
-18.13%
|
| Dec 31, 2014 | $1.71 B |
15.38%
|
| Dec 31, 2013 | $1.48 B |
30.00%
|
| Dec 31, 2012 | $1.14 B |
-90.91%
|
| Dec 30, 2011 | $12.50 B |
-11.29%
|
| Dec 31, 2010 | $14.10 B |
-48.76%
|
| Dec 31, 2009 | $27.51 B |
42.35%
|
| Dec 31, 2008 | $19.32 B |
-84.55%
|
| Dec 31, 2007 | $125.04 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Mesoblast
MESO
|
$2.03 B |
0.000 M
|
Australia
|
 Vericel
VCEL
|
$2.89 B |
0.000 M
|
USA
|
 Sangamo Therapeutics
SGMO
|
$0.24 B |
-0.000 M
|
USA
|
 Organogenesis
ORGO
|
$0.44 B |
-0.000 M
|
USA
|
 Lineage Cell Therapeutics
LCTX
|
$0.15 B |
-0.000 M
|
USA
|
 BrainStorm Cell Therapeutics
BCLI
|
$12.15 M |
0.000 M
|
USA
|
 Ocugen
OCGN
|
$0.22 B |
0.000 M
|
USA
|
 REGENXBIO
RGNX
|
$0.39 B |
-0.000 M
|
USA
|
| Market Cap | = | CAPR Stock Price | * | CAPR Shares Outstanding |
| = | $14.90 | * | 45.47 M | |
| = | $0.68 B |